Clinical Trials

Study Title:
Randomized Phase II Trial of Anti-LAG-3 and Anti-PD-1 Blockade vs. SOC in Patients With Recurrent Glioblastoma

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Lindhorst, Scott, at lindhors@musc.edu.
Study Coordinator, Newman, Eva, at newmanev@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina